TWO SIGMA ADVISERS, LP - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M601. A total of 39 filers reported holding ACORDA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.0%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$8,614
-25.1%
14,700
-2.0%
0.00%
Q4 2022$11,501
+187.5%
15,000
+1.4%
0.00%
Q3 2022$4,000
-42.9%
14,800
+2.8%
0.00%
Q2 2022$7,000
-69.6%
14,4000.0%0.00%
Q1 2022$23,000
-43.9%
14,400
-16.8%
0.00%
Q4 2021$41,000
-25.5%
17,300
+44.2%
0.00%
Q3 2021$55,00012,0000.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
CANYON CAPITAL ADVISORS LLC 649,031$1,045,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 244,090$393,0000.01%
United Asset Strategies, Inc. 27,100$44,0000.01%
Saltoro Capital, LP 14,848$24,0000.01%
ACADIAN ASSET MANAGEMENT LLC 467,739$751,0000.00%
Point72 Asset Management, L.P. 464,276$747,0000.00%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 22,600$36,0000.00%
Renaissance Technologies 707,218$1,139,0000.00%
Russell Investments Group, Ltd. 6,000$9,0000.00%
FIRST MANHATTAN CO. LLC. 50$00.00%
View complete list of ACORDA THERAPEUTICS INC shareholders